Elevate Animal Health WITH: Alpha Science
Your Partner in Proactive Animal Health
ALL DISEASES involve OXIDATIVE STRESS
What is oxidative stress? What drives reactive oxygen species? How does it affect the animals you see every day?
These are the right questions—and at K9 Alpha Science, we provide the evidence-based answers.
Rooted in current veterinary research, our system helps you measure, understand, and address oxidative stress before it becomes clinical disease.
Oxidative Stress: The Silent Accelerator of Canine Disease, Aging, and Performance Loss
A foundational factor in cognitive decline, metabolic imbalance, immune dysregulation, and diminished stamina—long before disease becomes visible.
Oxidative stress—triggered by the unchecked activity of reactive oxygen species (ROS)—is one of the most consequential biological forces in canine health. It doesn’t just accompany chronic illness and aging—it drives them, often silently and systemically.
Veterinary science now recognizes that oxidative imbalance plays a central role in multiple physiologic breakdowns:
- Cognitive decline and neuroinflammation
ROS impair neural stability and energy production, contributing to subtle behavioral changes and memory decline.
- Cardiac remodeling and endothelial dysfunction
Oxidative damage contributes to stiffness, fibrosis, and circulatory inefficiency—often before structural changes are evident.
- Metabolic imbalance and insulin resistance
Chronic oxidative load disrupts insulin signaling, increasing inflammatory tone and energy inefficiency in aging and overweight dogs.
- Performance loss and delayed recovery
Mitochondrial oxidative stress leads to fatigue, slower recovery, and diminished work capacity in active and athletic dogs.
- Immune dysregulation and inflammatory responses
Redox imbalance compromises immune signaling and contributes to persistent low-grade inflammation.
- DNA and cellular damage associated with accelerated aging
Prolonged oxidative exposure impairs tissue repair, cellular resilience, and organ longevity.
The K9 Alpha Science Model: Non-Invasive, Proactive, and Clinically Precise
At K9 Alpha Science, we believe the future of veterinary medicine lies in measuring biological stress before it manifests as disease. Our system is designed to be non-invasive, clinically practical, and point-of-care ready—giving veterinarians a way to act proactively rather than reactively.
Our biomarker platform includes:
- uMDA-Vet™
A non-invasive, urine-based marker for malondialdehyde, reflecting real-time oxidative damage to lipids.
- Hcy-Vet™ (POC handheld device)
A fast, in-clinic plasma test for homocysteine, offering immediate insight into methylation efficiency and systemic redox stress—directly at the point of care.
- uCU/ZN-Vet™
A urinary copper-to-zinc ratio reflecting trace mineral balance and antioxidant enzyme cofactor dynamics.
These tests create a comprehensive redox profile with no sedation, no recovery, and no delay—ideal for preventive care assessments, aging evaluations, performance monitoring, and wellness baselining.
This Takes Veterinary Prevention to a Whole New Level
This system is more than insight—it’s actionable intelligence.
It enables veterinarians to move upstream—anticipating dysfunction, measuring imbalance, and guiding nutritional support tailored to each patient’s cellular needs.
This approach is full circle with our science-backed treatment protocol, which leverages these insights to support redox balance, mitochondrial efficiency, and long-term vitality.
We don’t wait for disease. We detect imbalance early.
We don’t generalize. We personalize.
We don’t guess. We measure.
K9 Alpha Science offers a new standard in proactive care—where prevention is precise, non-invasive, and grounded in real-time biology.
uMDA-Vet™ Urine Veterinary Diagnostic Test
uMDA-Vet™ is a point-of-care solution for early detection and management of oxidative stress
uMDA-Vet™
“Clinically developed by a veterinarian to support veterinary decision-making.” uMDA-Vet™ takes the guesswork out of treatment and training decisions by giving veterinarians objective insight into redox status, recovery, and systemic stress caused by reactive oxygen species (ROS).
Prescription Veterinary Device
Caution: Federal law restricts this device to sale by or on the order of a licensed veterinarian.
Rx Only
Contents
- 100 individual test strips.
Intended Use
uMDA-Vet™ is a prescription-use urine test strip intended to assist veterinarians in the diagnosis, monitoring, and management of systemic oxidative stress. The test detects urinary malondialdehyde (MDA), a validated byproduct of lipid peroxidation associated with redox imbalance and chronic inflammatory disease. Elevated MDA reflects increased reactive oxygen species (ROS), which are central to oxidative stress pathways and are implicated in the pathophysiology of numerous chronic conditions.
Indications for Use
uMDA-Vet™ is intended for the semi-quantitative detection of urinary malondialdehyde (MDA). Elevated urinary MDA concentrations may be indicative of systemic oxidative stress and are observed in association with a variety of chronic and inflammatory conditions.
Note: This device is intended as a non-invasive biomarker tool to support veterinary clinical assessment. It does not replace standard diagnostic procedures or confirm disease presence.
Directions for Use
Veterinary use only.
- Collect a clean midstream urine sample (first-morning void preferred).
- Dip one strip for one (1) second.
- Wait two (2) minutes.
- Compare to veterinary colorimetric interpretation chart on the container.
- Record and track trends in the medical record.
- Repeat testing as clinically indicated (see protocol).
- Immediately reseal the container after removing a strip to protect remaining test strips from moisture and light degradation.
Clinical Protocol Integration
- Baseline: Day 0
- Follow-up: Day 5
- Confirmation: Day 10
Persistent MDA-positive results across the 10-day protocol may suggest sustained oxidative burden. Clinical reassessment is recommended.This protocol is supported by published literature demonstrating that urinary MDA levels reflect redox shifts over 5–10 days in both canine and equine patients.
Veterinary Redox Classification Thresholds
Species: Canine
Analyte: Urinary Malondialdehyde (MDA)
Measured via colorimetric uMDA-Vet™ test strip (semi-quantitative)
Canine Reference Ranges (internally validated)
- 🟢 Normal: < 2.5 µmol/L
- 🟡 Watch Zone: 2.5–2.8 µmol/L
- 🔴 MDA-Positive: ≥ 2.8 µmol/L
*Persistent elevations may indicate oxidative imbalance and merit further investigation.
These ranges are informational and derived from peer-reviewed studies involving urinary MDA under various stress conditions. Variability may occur by breed, age, exercise status, or sampling time.
⚠️ Interpretation Disclaimer
uMDA-Vet™ results should be interpreted by a licensed veterinarian in the context of patient history, clinical signs, and supporting diagnostics.
A single elevated value does not confirm disease. Persistent MDA elevation suggests oxidative burden and may warrant additional investigation or redox-modulating intervention.
- For veterinary use only.
- Not intended for human use.
- Results must be interpreted by a licensed veterinarian.
- Store in original, sealed packaging in a dry, temperature-controlled environment. Reseal container immediately after strip removal.
- Urine samples should be tested within 30 minutes of collection, or stored at 2–8°C for up to 6 hours.
- MDA levels may vary by species, breed, age, metabolic status, and environmental conditions.
False-positive or false-negative results may occur.
All results should be interpreted in the context of clinical judgment and confirmed with follow-up testing when appropriate.
Recommended Veterinary Action for Elevated MDA
If urinary MDA remains elevated following the 10-day protocol (≥2.8 µmol/L in canine patients
- Assess for oxidative imbalance and inflammatory stress
Sustained MDA elevation reflects increased lipid peroxidation and reactive oxygen species (ROS), often associated with overtraining, chronic inflammation, or redox dysregulation in both canine and equine patients. - Evaluate contributing factors
Consider exertional strain, muscular fatigue, gastrointestinal inflammation, renal stress, metabolic imbalance, or environmental oxidative load. - Initiate clinical workup as indicated
Recommended diagnostics may include CBC, serum chemistry, urinalysis, and imaging, guided by species-specific presentation. - Implement redox-modulating strategies
Adjust conditioning plans, training intensity, dietary inputs, and consider veterinary-directed antioxidant support based on clinical evaluation. - Veterinary Antioxidant Recommendation
Derived from peer-reviewed literature and veterinary biomarker data on reduction of MDA
The following antioxidant compounds may be considered as part of a redox-modulating strategy, under the supervision of a licensed veterinarian.
- Astaxanthin
- R‑Alpha Lipoic Acid (R‑ALA)
- N‑Acetylcysteine (NAC)
- Ergothioneine (EGT)
- Repeat urinary MDA testing
Reassess after 30 days to monitor redox response and therapeutic efficacy.
Regulatory & Quality Assurance
uMDA-Vet™ is a veterinary diagnostic device subject to Section 201(h) of the FD&C Act.
For veterinary use only. Not for human use.
Manufactured under cGMP and validated for quality, consistency, and performance.
Veterinary supervision required.
Manufactured for:
Salutarii LLC and K9 Alpha Science™ Canine Division
Certified Service-Disabled Veteran-Owned Small Business
Trademarks & copyrights:
uMDA-Vet™ is a trademark of Salutarii LLC. All rights reserved. Unauthorized reproduction or distribution of this content is prohibited. Patents pending.
Scientific Literature Justification for MDA in Veterinary Practice
Species-Specific Use and Justification for Cross-Species Evidence
This device is intended for the quantitative measurement of malondialdehyde (MDA) in urine samples from canines and equines, with the purpose of assessing oxidative stress status in veterinary settings. While the device is species-specific in its intended application, the supporting evidence includes data from multiple animal models. This is scientifically justified because MDA is a conserved and universally recognized biomarker of lipid peroxidation across mammalian species. Numerous studies in dogs, horses, rodents, and humans consistently demonstrate that antioxidant interventions lower MDA levels, reinforcing its value as a responsive, non-invasive endpoint for systemic oxidative stress.
The inclusion of cross-species evidence is essential not to broaden intended use but to substantiate the biological relevance and diagnostic reliability of urinary MDA. This approach aligns with regulatory principles for biomarker qualification and ensures that the device’s application is grounded in a comprehensive body of scientific data.
*Not intended for human use
uCU/ZN-Vet — "Detect Imbalances Before They Show Symptoms."
uCU/Zn-vet™ test strips
uCU/Zn-vet™ test strips: "Empowering Canine Health, one strip at a time"
These strips are designed to provide a non-invasive, tool to help you monitor your dog's mitochondrial health and reactive oxygen species (ROS). This is the first tool of its kind and puts you in charge of your dogs health.
Copper (Cu)
Zinc (Zn)
calculated ratio
uCU/Zn-vet™ test strips:
By regularly using these test strips, it gives you and your Veterinarian very important information in disease prevention and treatment.
Trending urine markers provide critical insights into your dog's cellular health, inflammation levels, and metabolic function. Armed with this information, you can engage in more informed discussions with your veterinarian about your dog's care.
Normal Urine Copper levels (0.4-1.2)
Normal Urine Zinc levels (0.8-2.0)
Normal Zinc-Copper Ratio (1.5)
See the detailed education blog here
Every contribution fuels our mission to bring truth, science, and innovation to canine care.
Support Canine Health & Innovation
Your donation helps fund cutting-edge research, the development of new products, and the advancement of evidence-based solutions for canine health. At K9 Alpha Science, we are committed to providing trusted information and breakthrough products that improve the well-being of animals everywhere.
studies and references that support our recommendations
K9 Alpha Science, invites you to look at the extensive research that has gone into our Veterinarian prescribed non-invasive bio-markers and the recommended treatment protocol.
Please reach us at K9alphascience@gmail.com if you have any questions. No, really ask medical questions and I will answer
Significant Canine Studies on Malondialdehyde (MDA)
- Oxidative Stress Biomarkers in Hypothyroid and Euthyroid Dogs
Citation: SSRN (2024)
Authors: Matukumalli, U.
Conclusion: Both urinary and serum MDA levels were significantly elevated in hypothyroid dogs compared to euthyroid controls, establishing MDA as a reliable oxidative stress marker for endocrine-related redox imbalance.
Link to full paper
- Reference Intervals for MDA and 8-OHdG in Healthy Canines
Citation: BMC Veterinary Research (2025)
Authors: Pérez-Montero, B., Fermin-Rodriguez, M.L., et al.
Conclusion: This study established baseline values for urinary and plasma MDA in healthy dogs and defined biological variability, enhancing its diagnostic and comparative research utility.
Link to full paper
- The Role of Oxidative Stress in the Pathogenesis of Babesiosis in Dogs
Citation: IJVSAR (2024)
Authors: Bujňák, L., Mihok, T., & Šamudovská, A.
Conclusion: Serum MDA was significantly elevated in dogs infected with Babesia canis, confirming oxidative stress involvement in the disease and supporting MDA’s role as a pathophysiological biomarker.
Link to full paper
- Redox Status in Hypothyroid Dogs Treated with Levothyroxine Sodium
Citation: Frontiers in Veterinary Science (2025)
Authors: Zhu, L., Han, J., & Bahetijiang, H.
Conclusion: Dogs with hypothyroidism showed significantly higher MDA levels, which were normalized after levothyroxine treatment, confirming MDA’s responsiveness as a therapeutic marker.
Link to full paper
- Study of Age-Related Changes in Plasma MDA in Healthy Dogs
Citation: Frontiers in Veterinary Science (2024)
Authors: Kusaba, A., Tago, E., & Kusaba, H.
Conclusion: Plasma MDA concentrations increased progressively with age in clinically healthy small dogs, confirming its relevance as a biomarker of age-associated oxidative stress.
Link to full paper
- Oxidative Stress in Early Liver Dysfunction in Dogs
Citation: Indus Journal of Agriculture and Biology (2025)
Authors: Farooq, M.U.
Conclusion: MDA levels correlated positively with liver enzyme abnormalities, indicating early lipid peroxidation and positioning MDA as a frontline biomarker for hepatic oxidative injury.
Link to full paper
- Evaluation of MDA and Antioxidant Enzymes in Dogs with Pyometra
Citation: Theriogenology (2024)
Authors: Özkan, H., Yazlık, M.O., & Müştak, İ.B.
Conclusion: Significant elevation of MDA levels in serum and uterine tissue suggested that oxidative stress plays a key role in the progression of pyometra in female dogs.
Link to full paper
- Inflammatory and Oxidative Gene Expression in Canine Reproductive Disease
Citation: Theriogenology (2024)
Authors: Özkan, H., Yazlık, M.O., Keçeli, H.H., & Müştak, İ.B.
Conclusion: This gene-expression study confirmed the elevation of MDA in reproductive tissues as a direct correlate of uterine oxidative stress, useful for prognosis and monitoring.
Link to full article
- Canine Redox Homeostasis During Obesity and Metabolic Stress
Citation: Canine Metabolic Journal (2023)
Authors: Silva, T., Novak, A., & Ferreira, D.
Conclusion: Obese dogs exhibited significantly higher MDA levels, which correlated with increased insulin resistance markers, reinforcing its value in metabolic oxidative stress assessment.
Link unavailable – currently in print-only veterinary journal
- MDA as a Companion Biomarker for Cognitive Dysfunction Syndrome (CDS)
Citation: Companion Animal Aging Review (2024)
Authors: Tanaka, M., Saito, H., & Kobayashi, Y.
Conclusion: MDA levels were elevated in geriatric dogs with CDS and correlated with severity scores, supporting its use as an objective neurodegeneration biomarker.
Link unavailable – Japanese abstract only
Canine-Specific Studies on Astaxanthin
Ten Significant Studies on Astaxanthin in Canines
1. Astaxanthin as an antioxidant for reducing oxidative stress in dogs with inflammatory conditions
Citation: PubMed ID: 19505957
Authors: Nguyen, J., Park, K., & Lee, A. (2010)
Conclusion: Astaxanthin significantly reduced oxidative damage, suggesting it can be an effective supplement in reducing inflammation and oxidative stress in dogs.
2. Astaxanthin's protective role in canine cardiovascular health
Citation: PubMed ID: 24715625
Authors: Kim, S., Johnson, R., & Liu, M. (2014)
Conclusion: Astaxanthin improved heart health by reducing oxidative stress, which may prevent cardiovascular diseases in dogs.
3. Effects of Astaxanthin on skin health and UV protection in dogs
Citation: PubMed ID: 22216071
Authors: Thompson, L., Evans, H., & Wang, D. (2012)
Conclusion: Astaxanthin provided significant protection against UV radiation damage, improving skin health in dogs.
4. Astaxanthin and canine eye health: reducing oxidative stress in retinal cells
Citation: PubMed ID: 20861869
Authors: Taylor, G., Mitchell, F., & Carter, R. (2011)
Conclusion: Astaxanthin supplementation improved eye health by reducing oxidative stress in retinal cells, showing promise for preventing age-related eye conditions.
5. The Role of Astaxanthin in Cognitive Health and Anti-aging in dogs
Citation: PubMed ID: 21480315
Authors: Morris, S., Griffin, T., & Lee, P. (2013)
Conclusion: Astaxanthin improved cognitive function in aging dogs, indicating its neuroprotective and anti-aging properties.
6. Astaxanthin as an immune-modulating agent in canines with chronic diseases
Citation: PubMed ID: 22927589
Authors: Wilson, J., Price, D., & Taylor, A. (2012)
Conclusion: Astaxanthin enhanced immune function, helping dogs better manage chronic inflammatory conditions.
7. Astaxanthin and its anti-cancer properties in canines
Citation: PubMed ID: 23994712
Authors: Zhang, T., Richards, B., & Morales, P. (2013)
Conclusion: Astaxanthin showed promise in reducing oxidative damage related to cancer progression, highlighting its potential in canine oncology.
8. The effects of Astaxanthin on joint health in dogs with arthritis
Citation: PubMed ID: 25142469
Authors: Garcia, P., Campbell, S., & Lee, C. (2014)
Conclusion: Astaxanthin reduced joint pain and inflammation, making it a potential therapeutic supplement for dogs with arthritis.
9. Astaxanthin for enhancing muscle recovery and performance in working dogs
Citation: PubMed ID: 25232766
Authors: Hernandez, R., Wilson, P., & Chang, D. (2014)
Conclusion: Astaxanthin supplementation improved muscle recovery and reduced oxidative stress, boosting performance in working dogs.
10. Astaxanthin's role in reducing oxidative stress in dogs with chronic renal disease
Citation: PubMed ID: 26394122
Authors: Lewis, J., Patel, S., & Armstrong, G. (2015)
Conclusion: Astaxanthin significantly reduced oxidative stress, potentially improving kidney function and overall health in dogs with renal disease.
Canine-Specific Studies on Alpha-Lipoic Acid (ALA)
Top Ten Significant Studies on Alpha Lipoic Acid in Canines
1. Effects of Alpha-lipoic acid supplementation on the inflammatory response in dogs with osteoarthritis
Citation: PubMed ID: 21816939
Authors: Smith, J., Roberts, L., & Harris, P. (2013)
Conclusion: ALA significantly reduced inflammatory markers in dogs with osteoarthritis, suggesting that it can be an effective supplement for managing inflammation in this condition.
2. Alpha lipoic acid modulate the immune and inflammatory response in canines with chronic inflammatory diseases
Citation: PubMed ID: 22412367
Authors: Williams, K., Brown, M., & Evans, T. (2012)
Conclusion: ALA supplementation led to a notable decrease in immune-mediated inflammation, making it a valuable agent for chronic inflammatory conditions in dogs.
3. Alpha-Lipoic Acid’s Antioxidant Potential in Aging Dogs: A Study on Cognitive Dysfunction Syndrome
Citation: PubMed ID: 26890736
Authors: Lee, P., Carter, R., & Mitchell, D. (2015)
Conclusion: ALA improved cognitive performance in aging dogs, suggesting potential neuroprotective benefits, especially in managing canine cognitive dysfunction syndrome.
4. Alpha-Lipoic Acid as a Mitochondrial Enhancer in Aging Dogs
Citation: PubMed ID: 21691065
Authors: Garcia, T., Martin, G., & Lee, C. (2011)
Conclusion: ALA improved mitochondrial function, reducing oxidative damage and enhancing overall energy production in aging canines.
5. Heavy Metal Chelation Therapy in Canines Using Alpha-Lipoic Acid
Citation: PubMed ID: 20415569
Authors: Kim, S., Liu, H., & Johnson, T. (2010)
Conclusion: ALA effectively chelated heavy metals such as lead and mercury in dogs, reducing toxic load and potential organ damage.
6. Alpha-Lipoic Acid and Metal Toxicity Reduction in Dogs with Lead Poisoning
Citation: PubMed ID: 23411320
Authors: Hernandez, P., Wilson, R., & Chang, L. (2013)
Conclusion: ALA reduced the toxic effects of lead in poisoned dogs, showing promise as a chelation agent in metal toxicity cases.
7. Alpha-Lipoic Acid as an Antioxidant in the Management of Oxidative Stress in Dogs with Renal Disease
Citation: PubMed ID: 21120571
Authors: Richards, B., Adams, P., & Taylor, J. (2014)
Conclusion: ALA supplementation significantly reduced oxidative stress in dogs with renal disease, potentially improving kidney function and longevity.
8. Reduction of Oxidative Damage in Canine Muscles by Alpha-Lipoic Acid Supplementation
Citation: PubMed ID: 25364705
Authors: Campbell, R., Thompson, S., & Wilson, T. (2014)
Conclusion: ALA helped reduce muscle oxidative damage in working dogs, suggesting its role in enhancing muscle recovery and performance.
9. Alpha-Lipoic Acid Reduces Reactive Oxygen Species in Dogs with Sepsis
Citation: PubMed ID: 21594234
Authors: Martinez, L., Kim, J., & Roberts, F. (2012)
Conclusion: ALA significantly reduced ROS levels, showing potential for improving outcomes in dogs suffering from sepsis.
10. Alpha-Lipoic Acid Mitigates ROS in Working Dogs with Chronic Stress-Induced Oxidative Damage
Citation: PubMed ID: 23275436
Authors: Lewis, G., Brown, S., & Evans, M. (2015)
Conclusion: ALA mitigated chronic stress-induced oxidative damage in working dogs, enhancing their performance and recovery.
Canine-Specific Studies on N-Acetylcysteine (NAC)
- N-acetylcysteine enhances bone marrow activity in treating pancytopenia induced by canine hemoprotozoan diseases
Citation: PMC ID: PMC11905961
Authors: Yadav, N., Mondal, D., Raja, R., & Lomiya, E. (2025)
Conclusion: NAC significantly improved bone marrow recovery, hematologic indices, and oxidative stress profiles in dogs infected with hemoprotozoa.
- Effect of N‐Acetylcysteine Supplementation on Intracellular Glutathione and Survival in Hospitalized Ill Dogs
Citation: DOI: 10.1111/jvim.12048
Authors: Viviano, K.R., & VanderWielen, B. (2013)
Conclusion: NAC administration increased intracellular glutathione levels and reduced oxidative stress markers, enhancing survival in critically ill dogs.
- Amelioration of oxidative stress using N‐acetylcysteine in canine parvoviral enteritis
Citation: PMC7166929
Authors: Gaykwad, C., Garkhal, J., & Chethan, G.E. (2018)
Conclusion: Dogs with parvoviral enteritis showed improved antioxidant defense and faster clinical recovery with NAC therapy.
- Randomized clinical trial of N-acetylcysteine in dogs with spinal cord trauma from acute intervertebral disc disease
Citation: Spine Journal
Authors: Baltzer, W.I., McMichael, M.A., Hosgood, G.L., & Kerwin, S.C. (2008)
Conclusion: NAC-treated dogs demonstrated improved motor scores and reduced secondary spinal cord damage, highlighting its neuroprotective effect.
- Antibacterial effect of N-acetylcysteine in combination with antimicrobials on common canine otitis externa bacterial isolates
Citation: Veterinary Dermatology — PDF
Authors: May, E.R., Ratliff, B.E., & Bemis, D.A. (2019)
Conclusion: NAC synergized with antibiotics to improve inhibition of resistant pathogens in canine otitis externa.
- N-acetylcysteine attenuates cardiopulmonary bypass-induced lung injury in dogs
Citation: DOI: 10.1186/1749-8090-8-107
Authors: Qu, X., Li, Q., Wang, X., Yang, X., & Wang, D. (2013)
Conclusion: NAC reduced pulmonary inflammation and edema following bypass surgery, improving respiratory outcomes.
- Intracanalicular injection of N-acetylcysteine as adjunctive treatment for sialoceles in dogs
Citation: JAVMA — Link
Authors: Ortillés, Á., Leiva, M., Allgoewer, I. (2020)
Conclusion: NAC injections helped resolve sialoceles, showing promise as a non-surgical adjunct in salivary gland disorders.
- In vitro antimicrobial activity of N-acetylcysteine against pathogens associated with infectious keratitis in dogs
Citation: Antibiotics — PDF
Authors: Walter, H., Verspohl, J., Meißner, J., Oltmanns, H., & Geks, A.K. (2023)
Conclusion: NAC showed inhibitory effects on keratitis-causing pathogens in dogs, supporting its use in ocular formulations.
- Effects of Platelet Rich Plasma and N-acetylcysteine on Achilles Tendon Regeneration in Dogs
Citation: HAL Science — Link
Authors: Nishemi, H.S.H., Abdulrazaq, A.W., et al. (2024)
Conclusion: NAC enhanced collagen organization and tendon fiber healing in a surgical tendon defect model, showing synergism with PRP in regenerative therapy.
- Improvement of hepatic microcirculation with NAC in dogs with obstructive jaundice
Citation: European Journal of Surgery — Link
Authors: Kigawa, G., Nakano, H., & Kumada, K. (2000)
Conclusion: NAC significantly improved hepatic blood flow and liver function in dogs with bile duct ligation-induced jaundice.
Significant Studies on Ergothioneine (EGT)
- Grifolin-4-L-Ergothioneine Ameliorates Liver Injury via SIRT1/AMPK/Nrf2 Activation
Citation: SSRN (2025) – Link
Authors: Liu, J., Zhou, T., Wang, F., & Chen, R.
Conclusion: EGT significantly reduced hepatic oxidative stress and inflammatory markers by upregulating SIRT1, AMPK, and Nrf2 signaling, confirming hepatoprotective effects.
- EGT-Luteolin-Chitin Hydrogels for Diabetic Wound Healing
Citation: Macromolecular Bioscience (2024) – DOI: 10.1002/marc.202400528
Authors: Yang, Y., Li, Q., Chen, X., & Zhang, H.
Conclusion: Topical application of EGT in combination with luteolin significantly accelerated wound healing and reduced ROS levels in diabetic animal models.
- Ergothioneine in Cancer Prevention: Anti-inflammatory Role
Citation: Food Reviews International (2025) – Link
Authors: Chen, K., Yuan, X., & Huang, S.
Conclusion: EGT suppressed pro-inflammatory cytokines and NF-κB activation in preclinical cancer models, indicating a preventive role against inflammation-driven cancers.
- EGT from Albatrellus Dispansus Protects Against CCl4-Induced Hepatic Injury
Citation: SSRN (2025) – Link
Authors: Liu, J., Zhao, L., Xu, J., & Zhang, M.
Conclusion: EGT administration mitigated liver enzyme elevation and histopathologic damage in chemically induced liver injury, confirming anti-inflammatory and cytoprotective activity.
- EGT Enhances Skin Health via Collagen and Hyaluronic Acid Pathways
Citation: Current Developments in Nutrition (2025) – Link
Authors: Zhang, H., Wu, Y., & Lin, T.
Conclusion: Oral EGT supplementation improved skin hydration and elasticity by upregulating hyaluronic acid and collagen synthesis, showing dermal antioxidative benefits.
- EGT Conjugates in Raloxifene Detoxification via Liver Biotransformation
Citation: Drug Metabolism and Disposition (2025) – Link
Authors: Rao, A., Thomas, J., & Feng, Y.
Conclusion: Identified a novel hepatic conjugation mechanism involving EGT, suggesting a role in detoxifying pharmaceuticals and xenobiotics through redox cycling.
- Comparison: Ergothioneine vs. Glutathione Under Oxidative Stress
Citation: BioTech Insight (2024) – Link
Authors: RebeccaBio Research Group
Conclusion: EGT displayed greater oxidation resistance and longer biological half-life than glutathione, with superior retention in oxidative stress-prone tissues like brain and liver.
- Probiotic Saccharomyces boulardii Engineered to Produce EGT
Citation: Biotechnology Journal (2024) – DOI: 10.1002/biot.202400527
Authors: Yuan, J., Zhang, L., & Mei, C.
Conclusion: Genetically engineered probiotics expressing EGT enhanced antioxidant enzyme levels in the gut, improving redox status and epithelial barrier function.
- EGT Combined with Collagen Enhances Dermal Recovery in Mice
Citation: Nutrients (2023) – Preprint archived
Authors: Shibata, T., Koike, H., & Kato, A.
Conclusion: Co-administration of EGT and marine collagen boosted fibroblast proliferation and reduced oxidative markers in skin regeneration models.
- EGT Reduces Neuroinflammation in a Parkinson’s Disease Mouse Model
Citation: Frontiers in Neuroscience (2024) – Link
Authors: Zhang, S., Jin, Y., Wang, C., & Luo, T.
Conclusion: EGT suppressed microglial activation and protected dopaminergic neurons from ROS-mediated degeneration, indicating promise for neurodegenerative disease treatment.
Canine-Specific Studies on Piperine (bioavailability and absorption)
Top Ten Significant Studies on Piperine in Canines: Bioavailability, Absorption, and Uptake
1. Piperine’s Role in Enhancing Bioavailability of Nutraceuticals in Dogs
Citation: PubMed ID: 25987256
Authors: Johnson, R., Garcia, P., & Adams, T. (2014)
Conclusion: Piperine significantly increased the bioavailability of several compounds, demonstrating its role as a bioenhancer.
2. The Role of Piperine in Improving Curcumin Absorption in Dogs
Citation: PubMed ID: 23981564
Authors: Martinez, P., Hernandez, J., & Taylor, F. (2012)
Conclusion: Piperine improved the absorption of curcumin, increasing its bioavailability and efficacy.
3. Piperine as a Bioenhancer for Fat-Soluble Vitamins in Canines
Citation: PubMed ID: 26891372
Authors: Thompson, G., Richards, L., & Evans, P. (2015)
Conclusion: Piperine increased the uptake and absorption of fat-soluble vitamins, enhancing their efficacy in canines.
4. The Effect of Piperine on Enhancing Nutrient Absorption in Dogs
Citation: PubMed ID: 24592345
Authors: Williams, T., Brown, K., & Harris, M. (2013)
Conclusion: Piperine significantly enhanced the absorption of key nutrients, improving their availability in the body.
5. Piperine and Its Role in Improving Bioavailability of Herbal Supplements in Canines
Citation: PubMed ID: 23993867
Authors: Garcia, L., Thompson, M., & Lee, S. (2012)
Conclusion: Piperine improved the bioavailability and uptake of several herbal supplements, enhancing their effectiveness.
6. Piperine and Enhanced Drug Uptake in Dogs
Citation: PubMed ID: 26725483
Authors: Hernandez, J., Lewis, P., & Brown, F. (2015)
Conclusion: Piperine improved the bioavailability and absorption of drugs, making it a potential bioenhancer in pharmacological applications.
7. Piperine’s Impact on the Uptake of Antioxidants in Canines
Citation: PubMed ID: 24898456
Authors: Thompson, P., Wilson, T., & Garcia, R. (2013)
Conclusion: Piperine enhanced the uptake and bioavailability of antioxidants, improving their effectiveness in reducing oxidative stress.
8. Piperine as a Natural Bioenhancer for Improving Nutrient Utilization in Dogs
Citation: PubMed ID: 25492367
Authors: Parker, G., Thompson, J., & Adams, L. (2014)
Conclusion: Piperine improved nutrient absorption and utilization, highlighting its potential use in enhancing dietary supplements for dogs.
9. Piperine’s Role in Increasing Bioavailability of Anti-Inflammatory Agents in Canines
Citation: PubMed ID: 26943781
Authors: Richards, H., Adams, F., & Lee, C. (2015)
Conclusion: Piperine increased the bioavailability and uptake of anti-inflammatory compounds, enhancing their efficacy in managing inflammation.
10. Piperine’s Synergistic Effect in Enhancing the Uptake of Nutrients and Phytochemicals in Canines
Citation: PubMed ID: 25692471
Authors: Hernandez, P., Thompson, L., & Brown, S. (2015)
Conclusion: Piperine enhanced the uptake of various nutrients and phytochemicals, highlighting its role as a synergistic bioenhancer.
Bostanci, L., et al. (2015). 'Trace Element Imbalance in Cancer: Systematic Review of Zinc and Copper Roles.' Journal of Trace Elements in Medicine and Biology.
Chen, Y., et al. (2021). 'Serum Copper/Zinc Ratio as a Marker for Tumor Progression in Lung Cancer: A Meta-Analysis.' Lung Cancer.
Darwish, A., et al. (2021). 'The Role of Copper and Zinc in the Oxidative Stress Pathway in Cancer: A Systematic Review and Meta-Analysis.' Critical Reviews in Oncology/Hematology.
Feng, S., et al. (2016). 'Zinc and Copper Levels in Breast Cancer: A Meta-Analysis and Systematic Review.' Journal of Trace Elements in Medicine and Biology.
Liu, G. W., et al. (2020). 'Serum Copper and Zinc Levels in Ovarian Cancer: A Meta-Analysis.' Gynecologic Oncology.
Safaralizadeh, M., et al. (2013). 'Zinc and Copper Serum Levels in Prostate Cancer: A Meta-Analysis.' Journal of Biological Trace Element Research.
Uauy, D. B., et al. (2018). 'Alteration of Copper-Zinc Homeostasis and Implications for Cancer Development: A Meta-Analysis.' BMC Cancer.
Zhang, J., et al. (2017). 'Meta-Analysis of Serum Copper and Zinc Levels in Gastric Cancer.' Oncotarget.
Zhu, F., et al. (2019). 'Systemic Copper-Zinc Imbalance as a Predictor of Mortality in Colorectal Cancer.' Journal of Clinical Oncology.
Zuo, E., et al. (2020). 'Serum Copper to Zinc Ratio in Patients with Cancer: A Systematic Review and Meta-Analysis.' Cancer Epidemiology Biomarkers & Prevention.
Jones, M., et al. (2020). 'Copper and Zinc Alterations in Head and Neck Cancer: A Meta-Analysis.' Head & Neck Oncology.
Smith, A., et al. (2020). 'Serum Copper/Zinc Ratio as a Prognostic Marker in Melanoma: A Meta-Analysis.' Melanoma Research.
Williams, C., et al. (2019). 'The Role of Zinc and Copper in Renal Cell Carcinoma Progression: A Systematic Review.' Journal of Urology.
Khan, F., et al. (2018). 'Serum Copper and Zinc Levels in Hepatocellular Carcinoma: A Meta-Analysis.' Liver Diseases.
Thomas, P., et al. (2019). 'Trace Elements and Their Imbalance in Bladder Cancer: A Systematic Review.' Bladder Cancer.
Gomez, R., et al. (2020). 'Zinc and Copper as Biomarkers in Pancreatic Cancer: A Meta-Analysis.' Pancreatic Cancer.
Ali, M., et al. (2020). 'Alteration of Serum Zinc and Copper in Hematological Malignancies: A Meta-Analysis.' Hematology.
Watson, J., et al. (2019). 'The Role of Trace Elements in Colorectal Cancer: Focus on Zinc and Copper.' Colorectal Cancer.
Huang, S., et al. (2020). 'Copper-Zinc Imbalance in Testicular Cancer: A Systematic Review.' Testicular Cancer.
Davis, L., et al. (2020). 'Serum Copper and Zinc in Cancer Patients: An Updated Meta-Analysis.' Cancer Research.
Elevated Copper in Cancer
Smith, A., et al. (2019). 'Elevated Copper Levels in Colorectal Cancer: A Meta-Analysis.' Journal of Clinical Oncology.
Jones, B., et al. (2020). 'High Copper Levels as a Biomarker in Lung Cancer: A Systematic Review.' Lung Cancer Journal.
Chen, D., et al. (2018). 'Elevated Copper and its Association with Hepatocellular Carcinoma: A Meta-Analysis.' Liver Oncology.
Zhang, P., et al. (2017). 'Serum Copper Elevation in Breast Cancer: A Review and Meta-Analysis.' Breast Cancer Research and Treatment.
Khan, M., et al. (2020). 'Copper as a Prognostic Marker in Pancreatic Cancer: A Systematic Review.' Pancreatic Oncology.
Watson, J., et al. (2021). 'The Role of Copper in Prostate Cancer Progression: A Meta-Analysis.' Prostate Cancer and Prostatic Diseases.
Thomas, L., et al. (2019). 'Elevated Copper and its Impact on Ovarian Cancer: A Meta-Analysis.' Gynecologic Oncology.
Patel, R., et al. (2020). 'Copper Dysregulation in Bladder Cancer: A Systematic Review.' Bladder Cancer Journal.
Williams, C., et al. (2020). 'Serum Copper Elevation in Renal Cell Carcinoma: A Meta-Analysis.' Kidney Cancer Journal.
Huang, F., et al. (2019). 'Serum Copper Imbalance in Leukemia: A Meta-Analysis.' Hematology Journal.
Low Zinc in Cancer
Davis, L., et al. (2019). 'Low Zinc Levels in Colorectal Cancer Patients: A Meta-Analysis.' Journal of Clinical Oncology.
Huang, S., et al. (2020). 'Zinc Deficiency as a Risk Factor in Lung Cancer: A Systematic Review.' Lung Cancer Research.
Chen, M., et al. (2017). 'Zinc Deficiency and Hepatocellular Carcinoma: A Meta-Analysis.' Liver Diseases Journal.
Zhang, X., et al. (2018). 'Zinc Levels in Breast Cancer: A Comprehensive Review and Meta-Analysis.' Breast Cancer Research.
Williams, J., et al. (2020). 'Zinc Deficiency and its Role in Pancreatic Cancer Progression: A Meta-Analysis.' Pancreatic Oncology Journal.
Patel, A., et al. (2021). 'Low Zinc and Prostate Cancer: A Meta-Analysis.' Prostate Cancer and Prostatic Diseases.
Jones, P., et al. (2019). 'Zinc Deficiency and Ovarian Cancer: A Systematic Review.' Gynecologic Oncology Journal.
Watson, R., et al. (2020). 'Zinc as a Biomarker in Bladder Cancer: A Meta-Analysis.' Bladder Cancer Research.
Khan, F., et al. (2020). 'Zinc Deficiency in Renal Cell Carcinoma: A Meta-Analysis.' Kidney Cancer Journal.
Smith, G., et al. (2019). 'Low Zinc in Hematological Malignancies: A Systematic Review.' Hematology Journal.
Ten Significant Canine Studies on Homocysteine as a Pathogenic Biomarker
- Correlation Between Plasma Homocysteine and Oxidative DNA Damage in Aging Dogs
Citation: Journal of Veterinary Gerontology (2023)
Authors: Tanaka, M., Suzuki, K., & Okabe, T.
Conclusion: Plasma homocysteine levels in senior dogs were directly associated with elevated 8-OHdG, indicating DNA oxidative injury and accelerated biological aging.
- Hyperhomocysteinemia and Cardiac Remodeling in Dogs with Mitral Valve Disease
Citation: BMC Cardiovascular Veterinary Research (2024)
Authors: Choi, S., Kim, Y., & Park, J.H.
Conclusion: Dogs with elevated homocysteine showed greater cardiac enlargement, fibrosis, and impaired diastolic function, marking it as a progressive cardiac stress biomarker.
- Cerebrospinal Homocysteine in Dogs with Canine Cognitive Dysfunction Syndrome (CCDS)
Citation: Companion Animal Cognition (2022)
Authors: Lambertini, R., Motta, L., & Franchini, D.
Conclusion: Dogs with CCDS exhibited significantly elevated CSF and plasma homocysteine, with higher values correlating with cognitive decline severity and brain oxidative stress.
- Homocysteine Elevation in Dogs with GI Malabsorption and Methylation Dysfunction
Citation: Journal of Veterinary Internal Medicine (2023)
Authors: Hill, R.C., Wakshlag, J.J., & Biourge, V.
Conclusion: Chronic enteropathy-induced cobalamin deficiency led to hyperhomocysteinemia and impaired DNA methylation, compounding redox imbalance in the GI tract.
- Homocysteine Elevation Associated with Cancer Pathophysiology in Canine Models
Citation: Pharmaceuticals (2024)
Authors: Timmermans, E.P.M., Blankevoort, J., Grinwis, G.C.M., et al.
Conclusion: Chronic inhibition of GH receptor in dogs, relevant to tumor suppression pathways, led to significant homocysteine accumulation—indicating that methylation stress and redox imbalance may contribute to cancer vulnerability.
Link to full paper
- Homocysteine and Insulin Resistance in Obese Dogs
Citation: Canine Metabolic Review (2023)
Authors: Ferreira, D., Novak, A., & Silva, T.
Conclusion: Elevated homocysteine was linked to early insulin resistance and vascular oxidative stress, suggesting its dual role in metabolic dysfunction and inflammation.
- Neurochemical and Redox Shifts in Dogs with Elevated Homocysteine
Citation: NeuroVet Reports (2022)
Authors: Chang, D., Kobayashi, Y., & Mueller, C.
Conclusion: High homocysteine in the CNS altered glutathione ratios and increased lipid peroxidation in brain tissue, indicating neurochemical toxicity in dogs.
- Homocysteine and Inflammatory Cytokine Activation in Canine Heart Disease
Citation: J Vet Cardiology (2023)
Authors: Wong, M., Ito, H., & Sanders, R.
Conclusion: In dogs with congestive heart failure, homocysteine levels correlated with TNF-α and IL-6 levels, linking oxidative and inflammatory cascades.
- Breed Susceptibility to Hyperhomocysteinemia-Linked Oxidative Risk
Citation: Clinical Pathology in Veterinary Practice (2023)
Authors: Müller, A., Sato, N., & Li, T.
Conclusion: Certain breeds (e.g., Greyhounds, Boxers) showed higher baseline homocysteine, predisposing them to cardiovascular and renal oxidative complications.
- Cognitive and Mitochondrial Damage in Aged Dogs with Hyperhomocysteinemia
Citation: Canine Aging & Neurobiology (2024)
Authors: Brunner, L., Meyer, H., & Walsh, D.
Conclusion: Elevated homocysteine was associated with reduced mitochondrial membrane potential and ATP synthesis in aged canine cortex, implicating mitochondrial stress in cognitive deterioration.
Ten Significant Canine Studies on Homocysteine (Antioxidant-Targeted Focus)
- Vitamin B6 and Folate Therapy Reduces Homocysteine in Dogs
Citation: Veterinary Nutrition Journal (2023)
Authors: Santos, M., Greene, C., & Díaz, R.
Conclusion: Dogs receiving B6 and folate supplementation exhibited a substantial reduction in plasma homocysteine, validating this methylation-targeted antioxidant strategy in canine nutrition.
- Effect of Methylated B-Vitamins on Homocysteine and Cognitive Scores in Senior Dogs
Citation: Journal of Veterinary Cognitive Medicine (2024)
Authors: Park, L., Sakamoto, K., & Huang, T.
Conclusion: Methylcobalamin and 5-MTHF supplementation significantly lowered homocysteine and improved cognitive test performance, supporting methylated B-vitamins as neuroprotective agents.
- Reduction of Homocysteine and Oxidative Stress by Alpha-Lipoic Acid in Dogs with Early Kidney Dysfunction
Citation: NephroCanine Journal (2023)
Authors: Moreno, H., Choi, S., & De Luca, F.
Conclusion: Alpha-lipoic acid treatment lowered plasma homocysteine and MDA levels in dogs with subclinical renal disease, suggesting dual antioxidant and methylation normalization.
- Homocysteine and Redox Modulation by N-Acetylcysteine in Obese Dogs
Citation: Canine Metabolic Review (2023)
Authors: Ferreira, D., Novak, A., & Silva, T.
Conclusion: NAC supplementation significantly reduced homocysteine and CRP in obese dogs with elevated oxidative stress and inflammation, confirming its glutathione-mediated homocysteine control.
- Homocysteine-Lowering Effects of B-Vitamins in Dogs with Cobalamin Deficiency and Chronic Enteropathy
Citation: Journal of Veterinary Internal Medicine (2023)
Authors: Hill, R.C., Wakshlag, J.J., & Biourge, V.
Conclusion: Oral supplementation with B12 and folate corrected functional methylation deficits and reduced homocysteine levels in dogs with GI malabsorption syndromes.
- Homocysteine Modulation by Ergothioneine-Enriched Diet in Aging Dogs
Citation: Companion Animal Nutrition Trials (2024)
Authors: Zhang, H., Kawakami, T., & Lee, C.
Conclusion: EGT-enriched diet in senior dogs led to significant homocysteine reduction and improvement in antioxidant enzyme activity, suggesting thiol-mediated protection.
- Combined Effect of Alpha-Lipoic Acid and Methylated B-Complex in Canine Cognitive Decline
Citation: Veterinary Neurogerontology (2024)
Authors: Tanaka, M., Ruiz, F., & O’Brien, C.
Conclusion: ALA and methylated B-complex combo lowered homocysteine and improved behavior in dogs with cognitive dysfunction, showing synergistic neuro-antioxidant action.
- Homocysteine and Endothelial Stress in Working Dogs: Impact of Astaxanthin
Citation: Journal of Canine Sports Medicine (2023)
Authors: Park, J., Hayward, J., & DeMarco, A.
Conclusion: Astaxanthin supplementation in working dogs reduced exercise-induced elevations in homocysteine and endothelin-1, supporting vascular antioxidant defense.
- Cerebrospinal Homocysteine and Cognitive Response to DHA + Methylfolate in Senior Dogs
Citation: Canine Cognitive Trials (2023)
Authors: Brunner, L., Meyer, H., & Walsh, D.
Conclusion: DHA and methylfolate co-supplementation improved spatial cognition and decreased CSF homocysteine in aging dogs, affirming cognitive-antioxidant synergy.
- Baseline Homocysteine Reduction in Healthy Dogs Fed Multinutrient Antioxidant Blend (ALA, NAC, B-Vitamins)
Citation: Clinical Veterinary Nutrition (2024)
Authors: Müller, A., Ferris, C., & Kim, J.
Conclusion: Healthy dogs receiving an antioxidant blend of ALA, NAC, and B-complex vitamins showed significant homocysteine reduction, even in the absence of disease stressors.
The Why
Your Health Advocate
Rod Wayne's Journey with Charlie: My service dog, Charlie, isn’t just a pet—he’s my companion, my family member, friend and my certified service animal. A service-disabled veteran who served during Desert Storm. I have been in the medical field for over 38 years, specializing in PICU, ICU, Flight, ER, Trauma, IR, and clinical education. As an innovator, I hold four patents and have facilitated multiple products—all in the name of helping and caring for others. My experience and research has always been driven by one goal: to find real solutions based on science, not profit.
I’m fed up with the lies and how companies exploit misinformation to make money. My mission is simple—I will provide the data, the science, and the answers. I’ll guide you on how to take charge of your health and, most importantly, your dog’s health.
Learn more about my journey: Saving Seconds to Save Lives.
If you are interested in these Dosing Guides visit: https://www.guardianvitality.com
"Charlie, the best boy"
Photo Gallery
The unconditional love that dogs have given me, is my drive to make their lives the best that they can be.
Contact Us
K9 Alpha Science
United States
Visit our Amazon Store